"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Pharmatest Services Ltd attends TRI-CON conference in San Francisco

Pharmatest Services Ltd attends Cambridge Healthtech Institute’s third annual conference on “Predictive Preclinical Models in Oncology” that will be held in the Moscone North Convention Center in San Francisco, CA, on February 16 – 18. Pharmatest has two scientific presentations in the conference and welcomes everyone to visit our booth #100.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. The third annual conference on “Predictive Preclinical Models in Oncology” is part of the “Cancer Channel” of the 22nd Annual Molecular Medicine Tri-Conference (Tri-Con). Pharmatest attends the conference with two scientific presentations that demonstrate development of novel clinically predictive preclinical efficacy models for oncology drug development.

Poster handouts will be available here after the start of the poster sessions:

"Novel human organotypic 3D myoma based invasion assay applicable as a preclinical tool for cancer drug development"

"Towards a more efficient ensemble of predictive models for cancer drug development with special focus on metastatic bone disease".

If you would like to schedule a meeting with our representatives during the conference, click here.